FOR GP-LED MEMORY CLINICS IN CARDIFF AND THE VALE OF GLAMORGAN

Location

Cardiff

Description

Cardiff and Vale University Health Board intends to renew their contract for the delivery of GP‑led memory clinics across Cardiff and the Vale of Glamorgan, supporting timely dementia assessment and enhancing dementia expertise within primary care.

Total Quantity or Scope

Cardiff and Vale University Health Board intends to award a contract for the provision of GP‑led memory clinics across Cardiff and the Vale of Glamorgan. The service will support earlier access to dementia assessment by reducing waiting times for patients seeking a diagnosis or an alternative explanation for cognitive symptoms. Delivering the service within a primary care setting will provide a more accessible, community‑based pathway for individuals with memory concerns. The model aims to build dementia expertise within local GP Practices by developing a cohort of GPs with enhanced skills and interest in dementia care. These GPs will deliver GP‑led diagnostic clinics within their practices, contributing to timely intervention, improved patient experience, and strengthened local dementia pathways. This contract will help Cardiff and Vale UHB enhance early identification, improve access to assessment, and support people to receive appropriate advice and care closer to home. This notice sets out the intention to award a contract following a Direct Award Process 2. The new contract Value is 204,847.50GBP. The previous contract operated over a three‑year period in annual intervals and was subsequently extended for a further 16 months, with an annual value of 77,047GBP. The new contract will run for 9 months, with the option to extend for a further 2 years in 12‑month intervals at the discretion of the Health Board. The contract is scheduled to commence on 1st July 2026, ending 31st March 2027, with potential extensions up to 31st March 2029.

Award Detail

Award Criteria

CPV Codes

• 85121100 - General-practitioner services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 25th June 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales

Other Information

This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Thursday 25th June 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales.’ Representations by providers must be made to decision makers by E-mail: marisa.riley2@wales.nhs.uk. Award Decision-Makers – Medicine Clinical Board, Cardiff and Vale University Health Board The Medicine Clinical Board approved the use of Direct Award Process 2 on the basis that there are no material changes to the service scope, requirements, or funding envelope. The service continues to operate under the same model, with consistent expectations and delivery arrangements already in place. The incumbent providers have demonstrated effective and reliable delivery and are well embedded within primary care settings, with established relationships and knowledge of local populations. Therefore, they are considered best placed to continue delivering the service without disruption. This approach ensures continuity, stability, and ongoing quality of provision, while also representing an efficient and proportionate route to maintain service delivery in line with Health Board priorities. No providers were excluded from the procurement process; There were no declared conflicts or potential conflicts of interest of individuals making the decision; Information that has not been published and is withheld under regulation 23(1) due to commercial sensitivity (WA Ref:163096)